Intelligence · Clinical Pipeline
Sana Biotechnology Pipeline
All ClinicalTrials.gov programs at Sana Biotechnology — phase, modality, and trial IDs.
- Programs
- 9
Quick answer
Sana Biotechnology has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AZITROMICINA ZENTIVA 500 mg compresse rivestite con film, Bassado 100 mg compresse, CEBION
Sana Biotechnology
Breast Cancer
1 trial -
Cisplatino Accord Healthcare Italia 1 mg/ml concentrato per soluzione per infusione, DOXORUBICINA ACCORD HEALTHCARE ITALIA 2 mg/ml concentrato per soluzione per infusione
Sana Biotechnology
Pleural carcinosis
1 trial -
DEFLAN 22,75 mg/ml gocce orali, sospensione
Sana Biotechnology
Laminopathies
1 trial -
Dexmedetomidine injection
Sana Biotechnology
Post Spinal Shivering
1 trial -
HCQ01
Sana Biotechnology
2019 Novel Coronavirus
2 trials -
Hydroxyurea
Sana Biotechnology
Thalassemia, Beta
1 trial -
Myocet (Non-pegylated liposomal doxorubicin (NPLD))
Sana Biotechnology
Breast Cancer
1 trial -
SUL-238, Identical to test product except without active substance
Sana Biotechnology
Parkinson’s Disease
1 trial -
TREDIMIN 25.000 U.I. /2,5 ml soluzione orale
Sana Biotechnology
haematologic condition who need staminal cells transplant
1 trial
Frequently asked questions
How many pipeline programs does Sana Biotechnology have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs